Joerg Hoernschemeyer

Title: Joerg Hoernschemeyer: Innovator in LNA Oligonucleotide Technology

Introduction

Joerg Hoernschemeyer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of oligonucleotide technology, particularly through his innovative work on LNA (Locked Nucleic Acid) oligonucleotides. His research has led to advancements that address critical challenges in the synthesis and application of these compounds.

Latest Patents

Hoernschemeyer holds a patent for the LNA-G process, which focuses on recent advancements in LNA oligonucleotides. This patent, identified as WO2014/I18267, addresses a specific problem encountered during the de-protection of LNA oligonucleotides that contain an aliphatic amine group and DMF-protected LNA G nucleoside. The issue results in the formation of a +28 Da impurity. His invention proposes the use of acyl protection groups on the exocyclic nitrogen of the LNA-G residue, offering a solution that improves the purity of the final product.

Career Highlights

Joerg Hoernschemeyer is currently associated with Roche Innovation Center Copenhagen A/S, where he continues to push the boundaries of oligonucleotide research. His work has been instrumental in developing new methodologies that enhance the efficacy and reliability of LNA-based therapeutics.

Collaborations

Throughout his career, Hoernschemeyer has collaborated with esteemed colleagues, including Dennis Jul Hansen and Jacob Ravn. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Joerg Hoernschemeyer's contributions to LNA oligonucleotide technology exemplify the impact of innovative thinking in scientific research. His patent for the LNA-G process addresses significant challenges in the field, showcasing his commitment to advancing biotechnology.